Thor Thorsson1, William W Russell1, Nour El-Kashlan1, Rachel Soemedi2, Jonathan Levine1, Sarah B Geisler1, Todd Ackley3, Aoy Tomita-Mitchell4, Jill A Rosenfeld5, Ana Töpf6, Marwan Tayeh3, Judith Goodship6, Jeffrey W Innis3,7, Bernard Keavney8, Mark W Russell1. 1. Department of Pediatrics and Communicable Diseases, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, Mich, USA. 2. Center for Computational Molecular Biology, Brown University, Providence, RI, USA. 3. Department of Pediatrics and Communicable Diseases, Division of Pediatric Genetics, University of Michigan, Ann Arbor, Mich, USA. 4. Department of Surgery, Medical College of Wisconsin, Milwaukee, Wis, USA. 5. Signature Genomic Laboratories, PerkinElmer, Inc., Spokane, Wash, USA. 6. Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom. 7. Department of Human Genetics, University of Michigan, Ann Arbor, Mich, USA. 8. Institute of Cardiovascular Sciences, Central Manchester University, Manchester, United Kingdom.
Abstract
OBJECTIVE: Congenital cardiac defects represent the most common group of birth defects, affecting an estimated six per 1000 births. Genetic characterization of patients and families with cardiac defects has identified a number of genes required for heart development. Yet, despite the rapid pace of these advances, mutations affecting known genes still account for only a small fraction of congenital heart defects suggesting that many more genes and developmental mechanisms remain to be identified. DESIGN: In this study, we reviewed 1694 described cases of patients with cardiac defects who were determined to have a significant chromosomal imbalance (a deletion or duplication). The cases were collected from publicly available databases (DECIPHER, ISCA, and CHDWiki) and from recent publications. An additional 68 nonredundant cases were included from the University of Michigan. Cases with multiple chromosomal or whole chromosome defects (trisomy 13, 18, 21) were excluded, and cases with overlapping deletions and/or insertions were grouped to identify regions potentially involved in heart development. RESULTS: Seventy-nine chromosomal regions were identified in which 5 or more patients had overlapping imbalances. Regions of overlap were used to determine minimal critical domains most likely to contain genes or regulatory elements involved in heart development. This approach was used to refine the critical regions responsible for cardiac defects associated with chromosomal imbalances involving 1q24.2, 2q31.1, 15q26.3, and 22q11.2. CONCLUSIONS: The pattern of chromosomal imbalances in patients with congenital cardiac defects suggests that many loci may be involved in normal heart development, some with very strong and direct effects and others with less direct effects. Chromosomal duplication/deletion mapping will provide an important roadmap for genome-wide sequencing and genetic mapping strategies to identify novel genes critical for heart development.
OBJECTIVE: Congenital cardiac defects represent the most common group of birth defects, affecting an estimated six per 1000 births. Genetic characterization of patients and families with cardiac defects has identified a number of genes required for heart development. Yet, despite the rapid pace of these advances, mutations affecting known genes still account for only a small fraction of congenital heart defects suggesting that many more genes and developmental mechanisms remain to be identified. DESIGN: In this study, we reviewed 1694 described cases of patients with cardiac defects who were determined to have a significant chromosomal imbalance (a deletion or duplication). The cases were collected from publicly available databases (DECIPHER, ISCA, and CHDWiki) and from recent publications. An additional 68 nonredundant cases were included from the University of Michigan. Cases with multiple chromosomal or whole chromosome defects (trisomy 13, 18, 21) were excluded, and cases with overlapping deletions and/or insertions were grouped to identify regions potentially involved in heart development. RESULTS: Seventy-nine chromosomal regions were identified in which 5 or more patients had overlapping imbalances. Regions of overlap were used to determine minimal critical domains most likely to contain genes or regulatory elements involved in heart development. This approach was used to refine the critical regions responsible for cardiac defects associated with chromosomal imbalances involving 1q24.2, 2q31.1, 15q26.3, and 22q11.2. CONCLUSIONS: The pattern of chromosomal imbalances in patients with congenital cardiac defects suggests that many loci may be involved in normal heart development, some with very strong and direct effects and others with less direct effects. Chromosomal duplication/deletion mapping will provide an important roadmap for genome-wide sequencing and genetic mapping strategies to identify novel genes critical for heart development.
Authors: Rejane A C Monteiro; Mariana L de Freitas; Gabrielle S Vianna; Valdirene T de Oliveira; Rafaella X Pietra; Luana C A Ferreira; Patrícia P O Rocha; Michele da S Gonçalves; Giovana da C César; Joziele de S Lima; Paula F V Medeiros; Juliana F Mazzeu; Fernanda S Jehee Journal: Mol Syndromol Date: 2017-06-14
Authors: Patrick Y Jay; Ehiole Akhirome; Rachel A Magnan; M Rebecca Zhang; Lillian Kang; Yidan Qin; Nelson Ugwu; Suk Dev Regmi; Julie M Nogee; James M Cheverud Journal: Mol Cell Endocrinol Date: 2016-08-20 Impact factor: 4.102
Authors: Steven C Glidewell; Shelley D Miyamoto; Paul D Grossfeld; David E Clouthier; Christopher D Coldren; Robert S Stearman; Mark W Geraci Journal: Clin Transl Sci Date: 2015-11-04 Impact factor: 4.689
Authors: Neil A Hanchard; Luis A Umana; Lisa D'Alessandro; Mahshid Azamian; Mojisola Poopola; Shaine A Morris; Susan Fernbach; Seema R Lalani; Jeffrey A Towbin; Gloria A Zender; Sara Fitzgerald-Butt; Vidu Garg; Jessica Bowman; Gladys Zapata; Patricia Hernandez; Cammon B Arrington; Dieter Furthner; Siddharth K Prakash; Neil E Bowles; Kim L McBride; John W Belmont Journal: Am J Med Genet A Date: 2017-06-27 Impact factor: 2.802
Authors: Neil A Hanchard; Shanker Swaminathan; Kristine Bucasas; Dieter Furthner; Susan Fernbach; Mahshid S Azamian; Xueqing Wang; Mark Lewin; Jeffrey A Towbin; Lisa C A D'Alessandro; Shaine A Morris; William Dreyer; Susan Denfield; Nancy A Ayres; Wayne J Franklin; Henri Justino; M Regina Lantin-Hermoso; Elena C Ocampo; Alexia B Santos; Dhaval Parekh; Douglas Moodie; Aamir Jeewa; Emily Lawrence; Hugh D Allen; Daniel J Penny; Charles D Fraser; James R Lupski; Mojisola Popoola; Lalita Wadhwa; J David Brook; Frances A Bu'Lock; Shoumo Bhattacharya; Seema R Lalani; Gloria A Zender; Sara M Fitzgerald-Butt; Jessica Bowman; Don Corsmeier; Peter White; Kelsey Lecerf; Gladys Zapata; Patricia Hernandez; Judith A Goodship; Vidu Garg; Bernard D Keavney; Suzanne M Leal; Heather J Cordell; John W Belmont; Kim L McBride Journal: Hum Mol Genet Date: 2016-03-09 Impact factor: 6.150